Delivery Order SPE2DB25D3201-SPE2DB26FNNTF
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,732.44 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic medication used in hospital and clinical settings. This competitively awarded, firm fixed-price delivery order was issued on September 10, 2025, with a completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 24, 2025, for the supply of Dalvance 500 mg vials, a specialty antibiotic medication. This firm fixed-price delivery order, valued at $5,719.88 with an ultimate completion date of October 27, 2025, was competitively awarded without set-aside designation. The award represents a child contract under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a $11.6K delivery order (Contract No. 4569867824) to AmerisourceBergen Drug Corp for Dalvance 500 mg vials, a specialty antibiotic medication. The order was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of October 30, 2025. Performance will occur at the contractor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate headquarters as a leading...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,426.25 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, a specialty antibiotic medication. This competitively awarded, firm fixed-price delivery order was issued on July 17, 2025, with an ultimate completion date of July 18, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, with a ceiling value of $2,743.74. The award, issued on September 4, 2025, was competitively awarded with no set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,284.07 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 15, 2025. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA Troop Support Medical. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for 500 mg vials of Dalvance (dalbavancin), a broad-spectrum antibiotic, with a ceiling value of $3,658.32. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and was awarded on August 4, 2025. This award carries no set-aside designation, indicating it was competitively awarded through open competition. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,481.35 delivery order to AmerisourceBergen Drug Corp for 500 mg Dalvance vials on April 22, 2025, with a completion date of April 23, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,688.81 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a specialty antibiotic used to treat bacterial skin infections. This firm fixed price delivery order, awarded on May 30, 2025, with completion expected by June 2, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply...
- The Defense Logistics Agency awarded a $16,882.84 delivery order to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, with an ultimate completion date of June 26, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of the agency's pharmaceutical procurement operations. The award leverages AmerisourceBergen's established position as a critical federal medical vendor, particularly within the Defense Logistics Agency's...